Cancer Research

Indiana Jones isn't the only one who has great adventures, apparently proteins do also. Researchers have uncovered a a slippery tube that funnels proteins into a 'chamber of doom' where they are shredded and recycled into the building blocks ...

Article - News Staff - Jul 12 2008 - 11:36am

Myosin-I Molecular Motor Detects Minute Changes In Force

Researchers at the University of Pennsylvania School of Medicine discovered that the activity of a specific family of nanometer-sized molecular motors called myosin-I is regulated by force. The motor puts tension on cellular springs that allow vibrations t ...

Article - News Staff - Jul 13 2008 - 12:23am

Raptor Pharmaceuticals Expands Board Of Directors And Scientific Advisory Board

NOVATO, California, July 14 /PRNewswire/-- Raptor Pharmaceuticals Corp. (OTC Bulletin Board: RPTP), today announced the appointments of Richard L. Franklin, M.D., Ph.D. to the Company's board of directors and Stephen C. Blacklow, M.D., Ph.D. to its s ...

Article - Anna Ohlden - Jul 14 2008 - 6:32am

Ulcer Bacterium Found In 700 Year-Old Mexican Mummy

Remnants of the bacterium that causes stomach ulcers, Helicobacter pylori, (H. pylori) have been discovered in gastric tissue from North American mummies. A study of human remains believed to predate Columbus' discovery of the New World has shown for ...

Article - News Staff - Jul 14 2008 - 11:26pm

AMT Starts Collaboration With St. Jude Children's Research Hospital On Gene Therapy For Hemophilia B. Company Accesses Exclusive

AMSTERDAM, The Netherlands, July 15 /PRNewswire/-- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today announced the start of a collaboration with St. Jude Children's Research Hospital in Memphis, Tenn ...

Article - Anna Ohlden - Jul 15 2008 - 12:32am

BioWa And Medarex Announce License Of BioWa's COMPLEGENT(TM) Technology

PRINCETON, New Jersey, July 16 /PRNewswire/-- BioWa, Inc. and Medarex, Inc. (Nasdaq: MEDX) announced today that they have entered into a license agreement which provides Medarex with the first ever access to BioWa's COMPLEGENT(TM) Technology for enha ...

Article - Anna Ohlden - Jul 16 2008 - 5:31am

Raptor Pharmaceuticals Enters Collaboration Agreement With UC San Diego In Liver Disease

NOVATO, California, July 16 /PRNewswire/--- Raptor to Support Phase 2a Clinical Trial at UCSD Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin Board: RPTP), today announced the execution of a collaboration agreeme ...

Article - Anna Ohlden - Jul 16 2008 - 6:32am

Galderma Announces Approval For Differin(R) Gel 0.1% In Japan

LAUSANNE, Switzerland, July 17 /PRNewswire/--- Based on the Largest Ever Clinical Program for Acne in Japan Galderma Pharma S.A., a global specialty pharmaceutical company focused on dermatology, announced today that Japan's Ministry of Health, Labor ...

Article - Anna Ohlden - Jul 16 2008 - 7:31pm

Organizational Changes At Silence Therapeutics

LONDON, July 17 /PRNewswire/-- Silence Therapeutics plc (London AIM: SLN), a leading European RNAi focused biotechnology company, announces that for personal reasons, Jeffery Vick has resigned as Group CEO and left the Company. The Board of Directors has ...

Article - Anna Ohlden - Jul 17 2008 - 11:31am

Apoptosis Mystery- Why Does It Sometimes Cause An Immune System Response?

Every moment we live, cells in our bodies are dying. One type of cell death activates an immune response while another type doesn't. Now researchers at Washington University School of Medicine in St. Louis and St. Jude's Children's Research ...

Article - News Staff - Jul 17 2008 - 12:10pm